Medical marijuana has drawn growing attention because cannabis and cannabinoid-based medicines may help with certain symptoms and conditions. But the strongest version of this article is not one that claims cannabis helps everything. It is one that shows where the evidence is strongest, where it is still developing, and where popular claims go too far.

According to NCCIH, the best-supported uses include certain rare seizure disorders, nausea and vomiting related to chemotherapy, loss of appetite and weight loss i

n HIV/AIDS, and modest benefits for chronic pain and multiple sclerosis symptoms.

One of the most common reasons patients explore medical cannabis is pain relief. Research reviewed by NCCIH suggests cannabis or cannabinoids may provide a small benefit for some kinds of chronic pain, especially neuropathic pain. But the benefit is often modest, and side effects are more common than with placebo. That makes cannabis less of a miracle cure and more of a possible option within a broader pain-management plan.

Another area with clearer evidence is chemotherapy-related nausea and vomiting. The FDA has approved dronabinol and nabilone, cannabinoid drugs related to THC, for this purpose, and NCI notes that these drugs have helped some patients when standard anti-nausea treatment was not enough. This is one of the strongest examples of cannabinoids already having a recognized medical role.

The evidence is even more specific in epilepsy. The FDA has approved Epidiolex, a purified CBD medicine, for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients age 1 and older. That does not mean all CBD products are proven seizure treatments, but it does show that a cannabis-derived medicine can be safe and effective for certain well-defined conditions when properly studied and regulated.

Medical cannabis has also been studied for multiple sclerosis symptoms, especially spasticity, and for some cancer-related symptoms such as pain, anxiety, appetite loss, and treatment side effects. But it is important to separate symptom relief from disease treatment. The National Cancer Institute notes that cannabis and cannabinoids have been studied to help manage cancer symptoms and side effects, while the FDA has not approved cannabis as a treatment for cancer itself. NCI also notes that claims that cannabis “cures” cancer are not supported by strong scientific evidence.

Mental health is where the conversation often becomes too simplistic. Some patients report that cannabis helps them feel calmer, sleep better, or cope more comfortably with illness. But official guidance does not support broad claims that marijuana reliably treats anxiety or depression, and NCCIH says research for many other conditions remains in early stages. The NCI also notes possible adverse effects including drowsiness, paranoia, hallucinations, and depression in some users.

Glaucoma is another place where the popular story needs correction. While marijuana can lower eye pressure for a short time, NCCIH says cannabis is not helpful for glaucoma, and the American Glaucoma Society explains that the effect is too short-lived and the side effects are too burdensome for it to be a practical long-term treatment.

So what are the real health benefits of medical marijuana? The most honest answer is that cannabis-related treatments can be genuinely useful in some settings, somewhat helpful in others, and still unproven in many of the ways people talk about them online. Its real potential lies in careful, evidence-based use — not in treating it as a cure-all. As research grows, medical cannabis may continue to earn an important place in symptom management, especially for pain, chemotherapy side effects, certain seizure disorders, and some neurological symptoms. But the strongest case for it is the truthful one: promising, useful in specific contexts, and still evolving.